Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system. This antibody drug is on track for pivotal testing that could show superiority over blockbuster AstraZeneca drugs that are standard treatments for a…
Sara Ratner is President of integrated Programs at Nomi Health. They work with employers and health plans to connect them to a network of providers (both telehealth and physical) who accept steep discounts in return for immediate payment. The employees in turn get no co-pay/no coinsurance. In addition they have an analytics company called Artemis…
OMNY Health — a national data ecosystem that facilitates biotech and medical research — launched a data network consisting of EHR data from more than 645,000 GLP-1 users. The data network seeks to give OMNY’s life sciences and health system partners a vast source of GLP-1 data that is related to patient demographics and social…
The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups that the move will sharply raise premiums and reduce affordable coverage. The post Health Experts Warn of ‘Devastating’ Impact After Senate Rejects ACA Tax Credit Extension appeared first on MedCity News.
When epidemiologist Sophia Newcomer tries to evaluate how well Montana might be able to ward off the measles outbreak spreading across the U.S., she doesn’t have much data to work with. A federal state-by-state survey last year showed that just over 86% of Montana’s 2-year-olds had recently received the measles, mumps, and rubella immunization. That…
By JASON HINES On August 1, 2025, Capital Women’s Care (CWC), one of the largest OB/GYN practices in the Mid-Atlantic region went out-of-network with UnitedHealthcare, affecting tens of thousands of women across Maryland, Virginia, Pennsylvania, and Washington D.C. The contract dispute between Capital Women’s Care (CWC) and UnitedHealthcare offers a fascinating case study in how price transparency…
Experts agree that the incoming Trump administration will likely shake things up in the prescription drug world — most notably when it comes to research and development, drug pricing and PBM reform. The post What Might the Future of Prescription Drugs Look Like Under Trump? appeared first on MedCity News.
AI-powered platforms can collect data sets from disparate sources and check them for quality, duplication, relevance, and more. These platforms can then create even more extensive, understandable findings to help healthcare professionals make decisions. The post To Help Achieve Life-Saving Discoveries, AI Must Access ‘Underutilized, Undervalued’ Findings appeared first on MedCity News.
By JEREMY SHANE What’s behind the coming health care reckoning? Most industry leaders have their preferred list of culprits: not us! Left-leaning critics blame large insurers, drug companies, and private equity firms. Take the profit and self-dealing out of health care. Those on the right blame excessive regulation, poorly-designed insurance markets, or limits on individuals’…
Suzy Lohman felt compelled to act when she learned that foster children treated at Cincinnati Children’s Hospital Medical Center often lacked proper bags for their belongings. Inspired by a hospital newsletter request for suitcases, duffel bags, and backpacks, Suzy launched a drive among EVS employees to collect these essential items. Many foster children, she knew, relied…